No detected hepatitis B virus-DNA in thalassemic patients infected by hepatitis C virus in Kerman Province of Iran

Pakistan Journal of Biological Sciences

Volumn 11, Issue 13, 2008, Pages 1738-1741

  Arababadi, Mohammad Kazemi ^a   Hassanshahi, Gholamhossein ^a   Yousefi, Hassan ^a   Zarandi, Ebrahim Rezazadeh ^a   Moradi, Mohammad ^a   Mahmoodi, Mahdi ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HBV DNA; Hepatitis B and thalassemic patients; Hepatitis C

Indexed keywords

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

VIRUS DNA;

ARTICLE; ENZYMOLOGY; FEMALE; FOLLOW UP; GENETICS; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; IRAN; ISOLATION AND PURIFICATION; LIVER; MALE; THALASSEMIA; TIME; VIROLOGY;

DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; IRAN; LIVER; MALE; THALASSEMIA; TIME FACTORS;

EID: 54049127401     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2008.1738.1741     Document Type: Article

References (19)

1. Allain, J.P., 2004a. Occult hepatitis B virus infection: Implications in transfusion. Vox Sang, 86: 83-91.
2. Allain, J.P., 2004b. Occult hepatitis B virus infection. Transfus Clin. Biol., 11: 18-25.
3. Cacciola, I., T. Pollicino, G. Squadrito, G. Cerenzia, M.E. Orlando and G. Raimondo, 1999. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N. Engl. J. Med., 341: 22-26.
4. Carpenter, P.A., M.L. Huang and G.B. McDonald, 2002. Activation of occult hepatitis B from seronegative patient after hematopoietic cell transplant: A cautionary tale. Blood, 99: 4245-4246.
5. Chakrabarti, S., P. Pradhan, A. Roy, M. Hira, G. Bandyopadhyay and D.K. Bhattacharya, 2006. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Indian J. Public Health, 50: 43-44.
6. Fukuda, R., N. Ishimura, M. Niigaki, S. Hamamoto and S. Satoh et al., 1999. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: Clinical and virological significance. J. Med. Virol., 58: 201-207.
7. Hu, K.Q., 2002. Occult hepatitis B virus infection and its clinical implications. J. Viral Hepatitis, 9: 243-257.
8. Jafarzadeh, A., M.K. Arababadi, M. Mirzaeel and A. Pourazar, 2008. Occult hepatitis B virus infection among blood donors with antibodies to hepatitis B core antigen. Acta Med. Iran, 46: 27-32.
9. Kashef, S., M. Karimi, Z. Amirghofran, M. Ayatollahi and M. Pasalar et al., 2008. Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients. Int. J. Lab. Hematol., 30: 11-16.
10. Kubo, S., A. Tamori, K. Ohba, T. Shuto and T. Yamamoto et al., 2001. Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis. Dig. Dis. Sci., 46: 2408-2414.
11. Marrero, J.A. and A.S. Lok, 2004. Occult hepatitis B virus infection in patients with hepatocellular carcinoma: Innocent bystander, cofactor, or culprit? Gastroenterology, 126: 347-350.
12. Matsuzaki, Y., T. Chiba and T. Hadama et al., 1997. HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan. Cancer Lett., 119: 53-61.
13. Mirmomen, S., S.M. Alavian, B. Hajarizadeh, J. Kafaee and B. Yektaparast et al., 2006. Epidemiology of hepatitis B, hepatitis C and human immunodeficiency virus infections in patients with beta-thalassemia in Iran: A multicenter study. Arch. Iran Med., 9: 319-323.
14. Oesterreicher, C., J. Hammer, U. Koch, F. Pfeffel, G. Sunder-Plassmann, D. Petermann and C. Muller, 1995. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int., 48: 1967-1971.
15. Pourazar, A., M. Salehi, A. Jafarzadeh A.M. Kazemi, F. Oreizi and K. Shariatinezhad, 2005. Detection of HBV DNA in HBsAg negative normal blood donors. Iran J. Immunol., 2: 172-176.
16. Rezvan, H., H. Abolghassemi and S.A. Kafiabad, 2007. Transfusion- transmitted infections among multitransfused patients in Iran: A review. Transfus Med., 17: 425-433.
17. Toyoda, H., K. Hayashi, Y. Murakami, T. Honda and Y. Katano et al., 2004. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J. Med. Virol., 73: 195-199.
18. Vedat, G., O. Hamza, T. Selahattin, S. Dede and K.K. Ali, 2006. Prevalence of occult HBV infection in haemodialysis patients with chronic HCV. World J. Gastroenterol., 12: 3420-3424.
19. Zhihua, L. and H. Jinlin, 2006. Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection. Int. J. Med. Sci., 3: 57-62.